Research and safety notice: This article is limited to chemical identity, NNMT biology, analytical research, cell experiments, animal studies, evidence limitations and UK regulation
Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, Hjerpsted JB
Clinical evidence shows these medications improve insulin sensitivity, lower fasting blood glucose, and reduce inflammation markers associated with metabolic disease
In short, it can help give you the appearance of having more hair overall
Experiments in islet cell models have shown that intracellular signalling after GLP-1R agonist binding occurs via two pathways, one of which (cyclic adenosine monophosphate generation) enhances insulin release, while the other (-arrestin recruitment) causes GLP-1R receptor internalisation, and hence reduces cellular sensitivity to ligand
This population is more likely to benefit from the potent metabolic and anti-inflammatory effects of the drug